Apimeds Pharmaceuticals US Inc
AMEX:APUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
|
P
|
Primech Holdings Ltd
NASDAQ:PMEC
|
SG |
|
LF Corp
KRX:093050
|
KR |
|
Xiamen Solex High-Tech Industries Co Ltd
SSE:603992
|
CN |
|
Genenta Science SPA
NASDAQ:GNTA
|
IT |
|
C
|
Centurion Corporation Ltd
SGX:OU8
|
SG |
|
C
|
China National Building Material Co Ltd
HKEX:3323
|
CN |
|
China Petrochemical Development Corp
TWSE:1314
|
TW |
|
GTS Internasional Tbk PT
IDX:GTSI
|
ID |
|
P
|
PT Temas Tbk
IDX:TMAS
|
ID |
Bankruptcy Probability
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Apimeds Pharmaceuticals US Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
22m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Apimeds Pharmaceuticals US Inc has total debt of 346.8k USD. This includes both short-term (0 USD) and long-term (346.8k USD) debt.
You can find a full breakdown on its Balance Sheet.
